CTFA/CHPA Urge Expanded Oral Health Care Indications
This article was originally published in The Tan Sheet
Executive Summary
FDA should broaden labeling guidance for the indications of OTC antigingivitis/antiplaque drug products under the "uses" heading to allow multiple descriptions of drug effects, the Joint Oral Care Task Group of the Consumer Healthcare Products Association and the Cosmetic, Toiletry & Fragrance Association recommends